federal_register: 2017-08182
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| document_number | title | type | abstract | publication_date | pub_year | pub_month | html_url | pdf_url | agency_names | agency_ids | excerpts | regulation_id_numbers |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2017-08182 | Safe Use Symposium: A Focus on Reducing Preventable Harm From Drugs in the Outpatient Setting | Notice | The Food and Drug Administration's (FDA or Agency) Center for Drug Evaluation and Research, Professional Affairs and Stakeholder Engagement Staff (PASES), is hosting a 1-day public symposium entitled "Safe Use Symposium: A Focus on Reducing Preventable Harm From Drugs in the Outpatient Setting." The purpose of this symposium is to discuss sources of preventable harm from drugs in the outpatient setting and to stimulate the exchange of ideas among thought leaders on interventions to reduce preventable harms and how these interventions can be studied. | 2017-04-24 | 2017 | 4 | https://www.federalregister.gov/documents/2017/04/24/2017-08182/safe-use-symposium-a-focus-on-reducing-preventable-harm-from-drugs-in-the-outpatient-setting | https://www.govinfo.gov/content/pkg/FR-2017-04-24/pdf/2017-08182.pdf | Health and Human Services Department; Food and Drug Administration | 221,199 | The Food and Drug Administration's (FDA or Agency) Center for Drug Evaluation and Research, Professional Affairs and Stakeholder Engagement Staff (PASES), is hosting a 1-day public symposium entitled "Safe Use Symposium: A Focus on Reducing Preventable... |